In practice, a combination of these approaches is used
GLP3 Planner adds explicit microdosing protocol support with pre-built schedules for twice-weekly, three-times-weekly, every-other-day, and daily dosing
Some patients carry genetic variants that reduce receptor sensitivity, meaning standard doses of Wegovy may never reach therapeutic potential in their system
Although this approach is still in its early stages of exploration within the GLP-1 space, continuous and semi-continuous chromatography is already gaining traction elsewhere, such as in oligonucleotide and biologics manufacturing
BMC Pregnancy and Childbirth
This is extremely rare and unlikely to be directly related to GLP-1 receptor agonists, but requires immediate medical evaluation regardless of cause